7.17 Live Broadcast of dacurry "China's liver cancer regulatory action - (CNLC) standard practice" strong.

In order to further improve the level of liver cancer diagnosis and treatment in China and standardize the guidance, promote the academic exchange of clinicians, the China Health Promotion and Education Association, together with the China Anti-Cancer Association Liver Cancer Professional Committee, will host the "China Liver Cancer Standard Action - (CNLC) Standard Practice" project, bring together experts in the field of liver cancer, share around the standard practice of cases, and conduct Multidisciplinary discussions on MDT to promote the practice of standard liver cancer diagnosis and treatment in clinical practice, improve the prognosis of liver cancer patients, and better provide better treatment services for patients with liver cancer.
China's Liver Cancer Standard Action - (CNLC) Standardized Practice" invites the industry's liver cancer diagnosis and treatment of multidisciplinary experts to conduct in-depth discussion sourcing clinical cases, to give the vast number of doctors the latest perspective and in-depth analysis.
through cross-regional, interdisciplinary "normative practice" multidisciplinary case discussion, so that liver cancer standard diagnosis and treatment really promote, implement and effective, and truly benefit patients.
this live meeting will be held on July 17 from 15:00 to 17:00, inviting Fudan University affiliated Zhongshan Hospital, Yan Jia, Professor Zhou Jian, Professor Shen Feng of the Third Affiliated Hospital of naval medical university, Professor Cai Jianqiang of the Oncology Hospital of the Chinese Academy of Medical Sciences, and the MDT expert team of the major hospitals to share and discuss online, scan the qr code below to participate in the live broadcast, please pay attention!